Pulse film
Function and Efficacy
1 Effect on thrombus formation and coagulation function: Maiping tablets can significantly affect experimental rat thrombus formation and have a good anticoagulant effect. 2 Lipid-lowering effect: Maiping tablets have a significant lipid-lowering effect on animal experimental hyperlipidemia models. 3 Hypoxia tolerance effect: Maiping tablets can significantly improve the hypoxia tolerance of experimental animals. 4 Toxicology tests confirmed: No toxic reactions or abnormal changes were observed in the acute and long-term toxicity tests of Maiping tablets, indicating that the drug is very safe and can be taken for a long time.
Ingredients
Ginkgo biloba leaf extract, vitamin C, rutin, polygonum multiflorum, angelica.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ginkgo biloba extractIngredients |
It has an effect on the formation of blood clots and coagulation function; it has the effect of lowering blood lipids; it improves the ability to tolerate hypoxia More |
90045-36-6 | 4 | |
| Ascorbic AcidIngredients |
It has an effect on the formation of blood clots and coagulation function; it has the effect of lowering blood lipids; it improves the ability to tolerate hypoxia More |
50-81-7 | 28 | |
| RutinIngredients |
It has an effect on the formation of blood clots and coagulation function; it has the effect of lowering blood lipids; it improves the ability to tolerate hypoxia More |
153-18-4 | 21 |
Appearance
This product is a film-coated tablet, which is brown after removing the coating; it has a fragrant smell and tastes sour and astringent.
Usage and Dosage
Oral administration: 4 tablets at a time, 3 times a day.
Adverse Reactions
No obvious toxic side effects were observed.
Precautions
Pregnant women should avoid taking the medicine.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
seal.
Packaging Specification
Each tablet weighs 0.28g
Validity Period
24 months
Manufacturer
Kangxian Duyiwei Biopharmaceutical Co., Ltd.
-
Founded in:
2014-03-06 -
Address:
Wangba Duyiwei Industrial Park, Kang County, Longnan City, Gansu Province -
Tax NO.:
916212240911941370 -
Registered Funds:
550 million yuan -
Email: